Clinical Trials Browser

Phase 1/2 × avelumab × Other solid neoplasm × Clear all

NCT03707808 2025-01-20

myDAvIpNi

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT03399552 2023-10-23

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

Phase 1/2 Completed

15 enrolled 8 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant